Uni-Bio and Luqa Pharma Partner to Market Dermatology Products in China

Uni-Bio Science of Hong Kong and Luqa Pharma, a China dermatology and aesthetics company, formed a partnership to co-market their respective dermatology drugs/devices in China. The three-year agreement includes currently approved and future dermatology products. Both companies market wound healing treatments, among others, in China, and both have existing marketing teams. Uni-Bio promotes GeneSoft, an in-licensed ophthalmic wound healing product, in China, and Luqa is responsible for marketing Stratpharma's Strataderm to treat scars and Laluxid for wound healing. More details.... Stock Symbol: (HK: 0690) Share this with colleagues: // //